{"slideshow_credits": null, "snippet": "Johnson & Johnson, a developer of the drug, has asked the agency to approve Xarelto to treat deep vein thrombosis and pulmonary embolism.", "abstract": "Johnson & Johnson says the Food and Drug Administration has agreed to give priority status to its review of three new uses for the anticlotting drug Xarelto; company is asking the agency to approve the drug to treat and then prevent return of deep vein thrombosis and pulmonary embolism.", "section_name": "Health", "print_page": "2", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/07/10/health/fda-expedites-review-of-new-uses-for-xarelto-an-anticlotting-drug.html", "lead_paragraph": "Johnson & Johnson, a developer of the drug, has asked the agency to approve Xarelto to treat deep vein thrombosis and pulmonary embolism.", "headline": {"seo": "F.D.A. Expedites Review of New Uses for Xarelto, an Anticlotting Drug", "main": "F.D.A. Expedites Review of New Uses for Anticlotting Drug", "print_headline": "F.D.A. Expedites Review of New Uses for Anticlotting Drug"}, "_id": "53f8a64e38f0d835538dcdbb", "word_count": "545", "multimedia": [{"height": 75, "url": "images/2012/07/10/business/Clot/Clot-thumbStandard.jpg", "legacy": {"thumbnail": "images/2012/07/10/business/Clot/Clot-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2012-07-10T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Johnson & Johnson", "name": "organizations", "is_major": "Y", "rank": "2"}, {"value": "Blood Clots", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "Y", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}